Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-29
2009-08-25
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S346000
Reexamination Certificate
active
07579351
ABSTRACT:
The present invention relates to compounds of formula Iwherein A, G, r and R1to R5are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
REFERENCES:
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4931463 (1990-06-01), Barbier et al.
patent: 4983746 (1991-01-01), Barbier et al.
patent: 5175186 (1992-12-01), Barbier et al.
patent: 5246960 (1993-09-01), Barbier et al.
patent: 5399720 (1995-03-01), Karpf et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 0 189 577 (1989-12-01), None
patent: 0 185 359 (1991-12-01), None
patent: 0 572 863 (1993-05-01), None
patent: 639573 (1994-07-01), None
patent: 0 524 495 (1996-10-01), None
patent: 0 443 449 (1997-05-01), None
patent: WO98/25920 (1998-06-01), None
patent: WO 99/34786 (1999-07-01), None
patent: WO 00/09122 (2000-02-01), None
patent: WO 00/09123 (2000-02-01), None
patent: WO00/46196 (2000-08-01), None
patent: WO 00/58293 (2000-10-01), None
patent: WO01/51466 (2001-07-01), None
patent: WO02/10169 (2002-02-01), None
patent: WO02/051844 (2002-07-01), None
patent: WO02/072584 (2002-09-01), None
patent: WO03/037327 (2003-05-01), None
patent: WO 03/064423 (2003-08-01), None
patent: WO 2005000849 (2005-01-01), None
Burks 1994 in Johnson L.R. ed., Physiology of the Gastrointestinal Tract, Raven Press, NY, pp. 211-242.
Leurs et al., Br J. Pharmacol. 1991, 102, pp. 179-185.
Raithel et al., Int. Arch. Allergy Immunol. 1995, 108, 127-133.
Panula et al., Proc. Natl. Acad. Sci. USA 1984, 81, 2572-2576.
Inagaki et al., J. Comp. Neurol 1988, 273, 283-300.
Arrang et al., Nature 1983, 302, 832-837.
Arrang et al., Neuroscience 1987, 23, 149-157.
Clapham & Kilpatrik, Br. J. Pharmacol. 1982, 107, 919-923.
Blandina et al. in The Histamine H3 Receptor (Leurs RL and Timmermann H eds, 1998, pp. 27-40, Elsevier, Amsterdam, The Netherlands.
Masaki et al; Endocrinol. 2003, 144, 2741-2748.
Hancock et al., European J. of Pharmacol. 2004, 487, 183-197.
Timmermann, J. Med. Chem. 1990, 33, 4-11.
H. Ishii et. al, Chem. Pharm. Bull. 1974, 22 (9), 1981.
T. Hino et. al, Chem. Pharm. Bull. 1990, 38 (1), 59.
M. Tani et. al, Heterocycles 1992, 34 (12), 2349.
L.I. Kruse, et. al, Journal of Organic Chemistry 1984, 49 (25), 4761.
T.J. Tewson et. al, J. Org. Chem. 2002, 67, 5164.
F. Zaragoza, et. al, J. Med. Chem. 2004, 47, 2833.
Amos B. Smith III et. al, J. Am. Chem. Soc. 1989, 111 (15), 5761-5768.
Takahashi, K, Tokita, S., Kotani, H. (2003) J. Pharmacol. Exp. Therapeutics 307, 213-218.
Cheng, Y, Prusoff, WH (1973) Biochem Pharmacol 22, 3099-3108.
M. Tordeux et. al, J. Fluorine Chem. 20, 301 (1982).
J. Org. Chem. 1974, 39, 3580.
Nettekoven Matthias
Plancher Jean-Marc
Richter Hans
Roche Olivier
Taylor Sven
Hoffmann-La Roche Inc.
Johnston George W.
McDowell Brian
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Tricyclic amide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic amide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic amide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4115227